((2R,8S,11S)-11-cyclopentyl-8-((R)-1-hydroxyethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecan-2-yl)boronic acid

ID: ALA5180525

PubChem CID: 168272810

Max Phase: Preclinical

Molecular Formula: C17H31BN4O7

Molecular Weight: 414.27

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)B(O)O)[C@@H](C)O)C1CCCC1

Standard InChI:  InChI=1S/C17H31BN4O7/c1-9(23)14(16(26)19-8-13(25)20-10(2)18(28)29)22-17(27)15(21-11(3)24)12-6-4-5-7-12/h9-10,12,14-15,23,28-29H,4-8H2,1-3H3,(H,19,26)(H,20,25)(H,21,24)(H,22,27)/t9-,10+,14+,15+/m1/s1

Standard InChI Key:  IFUXMXDTFQHFDE-QPNXVFALSA-N

Molfile:  

 
     RDKit          2D

 29 29  0  0  0  0  0  0  0  0999 V2000
   -5.0026   -0.6573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2881   -0.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2881    0.5803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5735   -0.6575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8588   -0.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1441   -0.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8588    0.5803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5734    0.9929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3880    1.8145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5865    1.8954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2544    1.1354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4295   -0.2449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1441   -1.4827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7148   -0.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0001   -0.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7148   -1.4827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0001   -1.8954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4295   -1.8954    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0001    0.5803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145   -0.6575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4292   -0.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1439   -0.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8586   -0.2449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1439   -1.4827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5732   -0.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2878   -0.2449    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    3.5732   -1.4827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2878    0.5803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0026   -0.6575    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  1
  8  7  1  0
  8  9  1  0
  9 10  1  0
 11 10  1  0
  7 11  1  0
  6 12  1  0
  6 13  2  0
 14 12  1  6
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  1
 15 19  2  0
 15 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 23 25  1  0
 25 26  1  0
 25 27  1  6
 26 28  1  0
 26 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5180525

    ---

Associated Targets(non-human)

SUB1 Subtilisin-like protease (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 414.27Molecular Weight (Monoisotopic): 414.2286AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Lidumniece E, Withers-Martinez C, Hackett F, Blackman MJ, Jirgensons A..  (2022)  Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.,  65  (19.0): [PMID:36137276] [10.1021/acs.jmedchem.2c01093]

Source